Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma: a RANO review

Regression of a meningioma during paclitaxel and bevacizumab therapy for breast cancer

(2012) Thomas J. Wilson et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Bevacizumab therapy for adults with recurrent/progressive meningioma: a retrospective series

(2012) Emil Lou et al.   JOURNAL OF NEURO-ONCOLOGY

Atypical and anaplastic meningiomas treated with bevacizumab

(2012) Lakshmi Nayak et al.   JOURNAL OF NEURO-ONCOLOGY

Radiographic regression of cranial meningioma in a NF2 patient treated by bevacizumab

(2011) S. Goutagny et al.   ANNALS OF ONCOLOGY

Phase II study of Gleevec® plus hydroxyurea (HU) in adults with progressive or recurrent meningioma

(2011) David A. Reardon et al.   JOURNAL OF NEURO-ONCOLOGY

Hydroxyurea for recurrent surgery and radiation refractory meningioma: a retrospective case series

(2011) Marc C. Chamberlain et al.   JOURNAL OF NEURO-ONCOLOGY

Hydroxyurea for recurrent surgery and radiation refractory high-grade meningioma

(2011) Marc C. Chamberlain   JOURNAL OF NEURO-ONCOLOGY

A phase I trial of erlotinib in patients with nonprogressive glioblastoma multiforme postradiation therapy, and recurrent malignant gliomas and meningiomas

(2011) J. J. Raizer et al.   NEURO-ONCOLOGY

Phase II study of subcutaneous octreotide in adults with recurrent or progressive meningioma and meningeal hemangiopericytoma

(2011) D. R. Johnson et al.   NEURO-ONCOLOGY

Bevacizumab-induced regression of anaplastic meningioma

(2010) M. J. A. Puchner et al.   ANNALS OF ONCOLOGY

Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group

(2010) Patrick Y. Wen et al.   JOURNAL OF CLINICAL ONCOLOGY

Medical therapies for meningiomas

(2010) Patrick Y. Wen et al.   JOURNAL OF NEURO-ONCOLOGY

Response Assessment in Neuro-Oncology

(2010) Eudocia C. Quant et al.   Current Oncology Reports

Advances in meningioma therapy

(2009) Andrew D. Norden et al.   Current Neurology and Neuroscience Reports

Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma

(2009) Andrew D. Norden et al.   JOURNAL OF NEURO-ONCOLOGY

Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08)

(2009) Patrick Y. Wen et al.   NEURO-ONCOLOGY

Interferon-α for recurrent World Health Organization grade 1 intracranial meningiomas

(2008) Marc C. Chamberlain et al.   CANCER